Some issues of sample size calculation for time-to-event endpoints using the Freedman and Schoenfeld formulas
This article deals with seven special issues related to the assumptions, applicability, and practical use of formulas for calculating power or sample size, respectively, for comparative clinical trials with time-to-event endpoints, with particular focus on the well-known Freedman and Schoenfeld meth...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
30 Jul 2015
|
| In: |
Journal of biopharmaceutical statistics
Year: 2015, Volume: 25, Issue: 6, Pages: 1285-1311 |
| ISSN: | 1520-5711 |
| DOI: | 10.1080/10543406.2014.1000546 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1080/10543406.2014.1000546 |
| Author Notes: | Ulrich R. Abel, Katrin Jensen, Irini Karapanagiotou-Schenkel & Meinhard Kieser |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1739065662 | ||
| 003 | DE-627 | ||
| 005 | 20220819030412.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 201118s2015 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1080/10543406.2014.1000546 |2 doi | |
| 035 | |a (DE-627)1739065662 | ||
| 035 | |a (DE-599)KXP1739065662 | ||
| 035 | |a (OCoLC)1341377888 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Abel, Ulrich |d 1952- |e VerfasserIn |0 (DE-588)14287552X |0 (DE-627)640555403 |0 (DE-576)333774582 |4 aut | |
| 245 | 1 | 0 | |a Some issues of sample size calculation for time-to-event endpoints using the Freedman and Schoenfeld formulas |c Ulrich R. Abel, Katrin Jensen, Irini Karapanagiotou-Schenkel & Meinhard Kieser |
| 264 | 1 | |c 30 Jul 2015 | |
| 300 | |a 27 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 18.11.2020 | ||
| 520 | |a This article deals with seven special issues related to the assumptions, applicability, and practical use of formulas for calculating power or sample size, respectively, for comparative clinical trials with time-to-event endpoints, with particular focus on the well-known Freedman and Schoenfeld methods. All problems addressed are illustrated by numerical examples, and recommendations are given on how to deal with them in the planning of clinical trials. | ||
| 650 | 4 | |a Controlled clinical trial | |
| 650 | 4 | |a Freedman formula | |
| 650 | 4 | |a Sample size | |
| 650 | 4 | |a Schoenfeld formula | |
| 650 | 4 | |a Time-to-event data | |
| 700 | 1 | |a Jensen, Katrin |d 1969-2020 |e VerfasserIn |0 (DE-588)118168061 |0 (DE-627)694729736 |0 (DE-576)291749240 |4 aut | |
| 700 | 1 | |a Karapanagiotou-Schenkel, Irini |e VerfasserIn |0 (DE-588)1101472952 |0 (DE-627)859729141 |0 (DE-576)469905905 |4 aut | |
| 700 | 1 | |a Kieser, Meinhard |d 1960- |e VerfasserIn |0 (DE-588)103276547X |0 (DE-627)739277766 |0 (DE-576)168963825 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of biopharmaceutical statistics |d Philadelphia, PA : Taylor & Francis, 1991 |g 25(2015), 6, Seite 1285-1311 |h Online-Ressource |w (DE-627)32047416X |w (DE-600)2008925-9 |w (DE-576)27387828X |x 1520-5711 |7 nnas |a Some issues of sample size calculation for time-to-event endpoints using the Freedman and Schoenfeld formulas |
| 773 | 1 | 8 | |g volume:25 |g year:2015 |g number:6 |g pages:1285-1311 |g extent:27 |a Some issues of sample size calculation for time-to-event endpoints using the Freedman and Schoenfeld formulas |
| 856 | 4 | 0 | |u https://doi.org/10.1080/10543406.2014.1000546 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20201118 | ||
| 993 | |a Article | ||
| 994 | |a 2015 | ||
| 998 | |g 103276547X |a Kieser, Meinhard |m 103276547X:Kieser, Meinhard |d 910000 |d 999701 |e 910000PK103276547X |e 999701PK103276547X |k 0/910000/ |k 1/910000/999701/ |p 4 |y j | ||
| 998 | |g 1101472952 |a Karapanagiotou-Schenkel, Irini |m 1101472952:Karapanagiotou-Schenkel, Irini |d 910000 |e 910000PK1101472952 |k 0/910000/ |p 3 | ||
| 998 | |g 118168061 |a Jensen, Katrin |m 118168061:Jensen, Katrin |d 910000 |d 999701 |e 910000PJ118168061 |e 999701PJ118168061 |k 0/910000/ |k 1/910000/999701/ |p 2 | ||
| 998 | |g 14287552X |a Abel, Ulrich |m 14287552X:Abel, Ulrich |d 50000 |d 910000 |d 999701 |e 50000PA14287552X |e 910000PA14287552X |e 999701PA14287552X |k 0/50000/ |k 0/910000/ |k 1/910000/999701/ |p 1 |x j | ||
| 999 | |a KXP-PPN1739065662 |e 3806713464 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"note":["Gesehen am 18.11.2020"],"origin":[{"dateIssuedKey":"2015","dateIssuedDisp":"30 Jul 2015"}],"title":[{"title":"Some issues of sample size calculation for time-to-event endpoints using the Freedman and Schoenfeld formulas","title_sort":"Some issues of sample size calculation for time-to-event endpoints using the Freedman and Schoenfeld formulas"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"language":["eng"],"person":[{"family":"Abel","display":"Abel, Ulrich","role":"aut","given":"Ulrich"},{"role":"aut","given":"Katrin","family":"Jensen","display":"Jensen, Katrin"},{"given":"Irini","role":"aut","display":"Karapanagiotou-Schenkel, Irini","family":"Karapanagiotou-Schenkel"},{"family":"Kieser","display":"Kieser, Meinhard","role":"aut","given":"Meinhard"}],"id":{"eki":["1739065662"],"doi":["10.1080/10543406.2014.1000546"]},"relHost":[{"language":["eng"],"part":{"issue":"6","volume":"25","extent":"27","text":"25(2015), 6, Seite 1285-1311","pages":"1285-1311","year":"2015"},"type":{"bibl":"periodical","media":"Online-Ressource"},"note":["Gesehen am 28.11.11"],"origin":[{"publisherPlace":"Philadelphia, PA ; New York, NY","dateIssuedDisp":"1991-","publisher":"Taylor & Francis ; Dekker","dateIssuedKey":"1991"}],"titleAlt":[{"title":"JBS"}],"title":[{"title":"Journal of biopharmaceutical statistics","title_sort":"Journal of biopharmaceutical statistics","subtitle":"JBS"}],"disp":"Some issues of sample size calculation for time-to-event endpoints using the Freedman and Schoenfeld formulasJournal of biopharmaceutical statistics","id":{"zdb":["2008925-9"],"eki":["32047416X"],"issn":["1520-5711"]},"recId":"32047416X","pubHistory":["1.1991 -"],"physDesc":[{"extent":"Online-Ressource"}]}],"physDesc":[{"extent":"27 S."}],"name":{"displayForm":["Ulrich R. Abel, Katrin Jensen, Irini Karapanagiotou-Schenkel & Meinhard Kieser"]},"recId":"1739065662"} | ||
| SRT | |a ABELULRICHSOMEISSUES3020 | ||